特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
934809

次世代シーケンシングの世界市場:製品別、技術別、エンドユーザー別、用途別、 地域別の競合、予測、機会

Global Next-generation Sequencing Market By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 118 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

次世代シーケンシングの世界市場:製品別、技術別、エンドユーザー別、用途別、 地域別の競合、予測、機会
出版日: 2020年05月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の次世代シーケンシング市場を調査したもので、各地域市 場の展望、市場の力学、主なトレンド、競合情勢と企業プロファイルなどの情報を 提供するとともに、戦略的提言を示しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の次世代シーケンス(NGS)市場の展望

  • 市場のエンドユーザーと予測
  • 市場シェアと予測
    • 製品別(消耗品、プラットフォーム、サービス)
    • 技術別(合成別シーケンス、イオン半導体シーケンス、ライゲーションによる シーケンス、パイロシーケンス、単一分子リアルタイムシーケンスおよびその他の テクノロジー)
    • エンドユーザー別(学術および臨床調査センター、製薬およびバイオテクノロ ジー企業、病院および診療所など)
    • 用途別(バイオマーカーおよび癌、診断、生殖に関する健康、個別化医療、農 業および動物調査およびその他のアプリケーション)
    • 地域別
    • 会社別(2019)

第6章 北米次世代シーケンス(NGS)市場の展望

  • 市場のエンドユーザーと予測
  • 市場シェアと予測
    • 製品別
    • 技術別
    • エンドユーザー別
    • 用途別
    • 国別(米国、カナダ、メキシコ、その他の北米)
  • 北米:国別分析
    • 米国の次世代シーケンス(NGS)市場の展望
    • カナダの次世代シーケンシング(NGS)市場の展望
    • メキシコの次世代シーケンス(NGS)市場の展望

第7章 欧州の次世代シーケンス(NGS)市場の展望

  • 市場のエンドユーザーと予測
  • 市場シェアと予測
    • 製品別
    • 技術別
    • エンドユーザー別
    • 用途別
    • 国別(フランス、ドイツ、英国、イタリア、スペイン、 その他欧州)
  • 欧州:国別分析
    • フランスの次世代シーケンス(NGS)市場の展望
    • ドイツの次世代シーケンス(NGS)市場の展望
    • 英国の次世代シーケンス(NGS)市場の展望
    • イタリアの次世代シーケンス(NGS)市場の展望
    • スペインの次世代シーケンス(NGS)市場の展望

第8章 アジア太平洋の次世代シーケンス(NGS)市場の展望

  • 市場のエンドユーザーと予測
  • 市場シェアと予測
    • 製品別
    • 技術別
    • エンドユーザー別
    • 用途別
    • 国別(中国、インド、日本、韓国、オーストラリア、およびその他アジア太平 洋地域)
  • アジア太平洋地域:国別分析
    • 中国の次世代シーケンス(NGS)市場の展望
    • インドの次世代シーケンス(NGS)市場の展望
    • 日本の次世代シーケンス(NGS)市場の見通し
    • 韓国の次世代シーケンス(NGS)市場の展望
    • オーストラリアの次世代シーケンス(NGS)市場の見通し

第9章 中東とアフリカの次世代シーケンス(NGS)市場の展望

  • 市場のエンドユーザーと予測
  • 市場シェアと予測
    • 製品別
    • 技術別
    • エンドユーザー別
    • 用途別
    • 国別(UAE、サウジアラビア、南アフリカ、中東およびアフリカのその他中東 の地域)
  • 中東・アフリカ地域:国別分析
    • 南アフリカの次世代シーケンス(NGS)市場の展望
    • サウジアラビアの次世代シーケンス(NGS)市場の展望
    • UAE次世代シーケンス(NGS)市場の展望

第10章 南米の次世代シーケンス(NGS)市場の展望

  • 市場のエンドユーザーと予測
  • 市場シェアと予測
    • 製品別
    • 技術別
    • エンドユーザー別
    • 用途別
    • 国別(ブラジル、アルゼンチン、コロンビア、その他)
  • 南米:国別分析
    • ブラジルの次世代シーケンス(NGS)市場の展望
    • アルゼンチンの次世代シーケンス(NGS)市場の展望
    • コロンビアの次世代シーケンス(NGS)市場の展望

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向

第13章 競合情勢 (NGSプラットフォームプロバイダー)

  • 競合の展望
  • 企業プロファイル
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc
    • BGI Group
    • Perkinelmer
    • Agilent Technologies, Inc.
    • Qiagen N.V.
    • F. Hoffmann-La Roche AG
    • 10x Genomics
    • Oxford Nanopore Technologies
    • Takara Bio

第14章 戦略的提言

第15章 免責事項

目次
Product Code: 4508

Global next-generation sequencing market is projected to grow at a CAGR of close to 20% to reach USD24 billion during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period. Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of global next-generation sequencing market over the coming years. However, some of the factors that might act as major impediments to the growth of global next-generation sequencing market includes concerns pertaining to the standards of NGS based diagnostics.

The global next-generation sequencing market is segmented based on product, technology, end user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing and other technologies. Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with rising demand for Illumina's systems as it uses the SBS technology.

Major players operating in the global next-generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Agilent Technologies, Inc., Qiagen N.V., Hoffmann-La Roche AG, 10x Genomics, Oxford Nanopore Technologies, Takara Bio and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global next-generation sequencing market.
  • To classify and forecast global next-generation sequencing market based on product, technology, end user, application, company and regional distribution.
  • To identify drivers and challenges for global next-generation sequencing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global next-generation sequencing market.
  • To conduct pricing analysis for global next-generation sequencing market.
  • To identify and analyse the profile of leading players operating in global next-generation sequencing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed new services, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global next-generation sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Next-generation sequencing service providers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to next-generation sequencing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendors and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global next-generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product:

Consumables

Platforms

Services

  • Market, By Technology:

Sequencing by Synthesis

Ion Semiconductor Sequencing

Sequencing by Ligation

Pyrosequencing

Single Molecule Real Time Sequencing

Other Technologies

  • Market, By End User:

Academic & Clinical Research Centers

Pharmaceutical & Biotechnology Companies

Hospitals & Clinics

Others

  • Market, By Application:

Biomarkers & Cancer

Diagnostics

Reproductive Health

Personalized Medicine

Agriculture & Animal Research

Other Applications

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • UAE
  • Saudi Arabia

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Next-generation Sequencing (NGS) Market Outlook

  • 5.1. Market End User & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Platforms and Services)
      • 5.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)
      • 5.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)
      • 5.2.1.3. By Services (Sequencing Services and Data management services)
    • 5.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing and Other Technologies)
    • 5.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)
    • 5.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Other Applications)
    • 5.2.5. By Region
    • 5.2.6. By Company (2019)
      • 5.2.6.1. By NGS Platform

6. North America Next-generation Sequencing (NGS) Market Outlook

  • 6.1. Market End User & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Application
    • 6.2.5. By Country (United States; Canada; Mexico and Rest of North America)
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next-generation Sequencing (NGS) Market Outlook
      • 6.3.1.1. Market End User & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Next-generation Sequencing (NGS) Market Outlook
      • 6.3.2.1. Market End User & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Next-generation Sequencing (NGS) Market Outlook
      • 6.3.3.1. Market End User & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application

7. Europe Next-generation Sequencing (NGS) Market Outlook

  • 7.1. Market End User & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Application
    • 7.2.5. By Country (France; Germany; UK; Italy; Spain and Rest of Europe)
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next-generation Sequencing (NGS) Market Outlook
      • 7.3.1.1. Market End User & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Next-generation Sequencing (NGS) Market Outlook
      • 7.3.2.1. Market End User & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Next-generation Sequencing (NGS) Market Outlook
      • 7.3.3.1. Market End User & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Next-generation Sequencing (NGS) Market Outlook
      • 7.3.4.1. Market End User & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Next-generation Sequencing (NGS) Market Outlook
      • 7.3.5.1. Market End User & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application

8. Asia-Pacific Next-generation Sequencing (NGS) Market Outlook

  • 8.1. Market End User & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Application
    • 8.2.5. By Country (China; India; Japan; South Korea; Australia; and Rest of Asia Pacific)
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next-generation Sequencing (NGS) Market Outlook
      • 8.3.1.1. Market End User & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. India Next-generation Sequencing (NGS) Market Outlook
      • 8.3.2.1. Market End User & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Next-generation Sequencing (NGS) Market Outlook
      • 8.3.3.1. Market End User & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Next-generation Sequencing (NGS) Market Outlook
      • 8.3.4.1. Market End User & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Next-generation Sequencing (NGS) Market Outlook
      • 8.3.5.1. Market End User & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. Middle East and Africa Next-generation Sequencing (NGS) Market Outlook

  • 9.1. Market End User & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Application
    • 9.2.5. By Country (UAE; Saudi Arabia; South Africa and Rest of Middle East & Africa)
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Next-generation Sequencing (NGS) Market Outlook
      • 9.3.1.1. Market End User & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. Saudi Arabia Next-generation Sequencing (NGS) Market Outlook
      • 9.3.2.1. Market End User & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. UAE Next-generation Sequencing (NGS) Market Outlook
      • 9.3.3.1. Market End User & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application

10. South America Next-generation Sequencing (NGS) Market Outlook

  • 10.1. Market End User & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Application
    • 10.2.5. By Country (Brazil; Argentina; Colombia; and Rest of South America)
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Next-generation Sequencing (NGS) Market Outlook
      • 10.3.1.1. Market End User & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Argentina Next-generation Sequencing (NGS) Market Outlook
      • 10.3.2.1. Market End User & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. Colombia Next-generation Sequencing (NGS) Market Outlook
      • 10.3.3.1. Market End User & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape (NGS Platform Providers)

  • 13.1. Competition Outlook
  • 13.2. Company Profiles
    • 13.2.1. Illumina, Inc.
    • 13.2.2. Thermo Fisher Scientific, Inc
    • 13.2.3. BGI Group
    • 13.2.4. Perkinelmer
    • 13.2.5. Agilent Technologies, Inc.
    • 13.2.6. Qiagen N.V.
    • 13.2.7. F. Hoffmann-La Roche AG
    • 13.2.8. 10x Genomics
    • 13.2.9. Oxford Nanopore Technologies
    • 13.2.10. Takara Bio

14. Strategic Recommendations

15. About Us & Disclaimer

(Note: The companies list can be customized based on the client requirements.)

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.